Airways Dysfunction Following WTC Dust Exposure

Pulmonary Diseases Clinical Trial

Official title:

Airways Dysfunction Following WTC Dust Exposure

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00395330
• Other study ID #: H06-714
• Status: Completed
• Phase: N/A
• First received: November 1, 2006
• Last updated: August 19, 2015
• Start date: April 2003
• Est. completion date: October 2006

Study information

• Verified date: August 2015
• Source: New York University School of Medicine
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Observational

Clinical Trial Summary

In the weeks following the terrorist attacks of September 11, 2001, many patients presented to their physicians with complaints related to exposure to the debris. These included nose and throat complaints (drip, congestion, sore throat), increased GE reflux (heartburn, regurgitation, retrosternal chest burning) and respiratory symptoms (worsening cough, wheezing, shortness of breath, chest tightness, sleep disturbance). In addition, there was a disproportionate rate of self-reported worsening asthma symptoms in patients living in Lower New York 5-9 weeks after the attack; those with exposure to the dust cloud fared worse. The functional abnormalities of firefighters with exposures to dust at the WTC site has been recently described. However, the effects of WTC dust exposure on pulmonary function in residents and workers near the WTC site remain unclear. This study will retrospectively review the charts of all patients referred to the pulmonary function laboratory for evaluation of symptoms following exposure to WTC dust. The main objectives for this study will be to characterize the functional abnormalities in these subjects.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 500
• Est. completion date: October 2006
• Est. primary completion date: October 2006
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years to 80 Years

Eligibility

Inclusion Criteria:

• age 18-80

• referral for pulmonary function evaluation of respiratory symptoms following exposure to WTC dust

Exclusion Criteria:

• inability to perform testing

Study Design

Observational Model: Ecologic or Community, Time Perspective: Retrospective

Related Conditions & MeSH terms

• Pulmonary Diseases

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
New York University School of Medicine